EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting virulence factors Psl and PcrV restores host defense in bronchiectasis and cystic fibrosis models

Wanhai Qin, Wayne Brailsford, Stacey Cromer Berman, Christina S Thornton, Antonio DiGiandomenico, Paul Kubes

Journal of Clinical Investigation · 16.11.2026 · 136 (22)

DOI: 10.1172/jci205523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 22.09.2026. Verfasst von Wanhai Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, and. Hauptthemen laut MEDLINE: Cystic Fibrosis, Bronchiectasis, Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic Pseudomonas aeruginosa infection is a central driver of bronchiectasis and contributes to progressive lung decline in patients with cystic fibrosis (CF), even in the era of CF transmembrane conductance regulator (CFTR) modulators. A major limitation in the field is that conventional mouse models fail to develop persistent, biofilm-associated lung infection, restricting mechanistic studies and preclinical evaluation. Here, we establish clinically relevant infection models by combining CF-like mouse strains (βENaC-overexpressing and CFTR-deficient mice) with agarose bead–embedded P . aeruginosa that forms persistent, tobramycin-refractory biofilms. Using intravital lung microscopy, we show that alveolar macrophages initially responded by surrounding biofilms but progressively dissociated from the biofilms during persistent infection. Neutrophils were also recruited but failed to clear bacteria. Administration of gremubamab (MEDI3902), a bispecific antibody targeting the virulence factors Psl and PcrV, preserved alveolar macrophages in persistent biofilm infection, restored bacterial sensing and phagocytosis, limited excessive neutrophilic inflammation, and significantly improved bacterial clearance and survival. Together, these findings establish a clinically relevant persistent P . aeruginosa infection model and highlight gremubamab as a promising virulence-targeted therapy to potentially overcome bacterial immune evasion while restoring host defense in mouse models of bronchiectasis and CF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisBronchiectasisPseudomonas aeruginosaPseudomonas InfectionsVirulence FactorsBacterial ProteinsAnimalsMiceDisease Models, AnimalBiofilmsMacrophages, AlveolarHumansNeutrophilsMice, KnockoutCystic Fibrosis Transmembrane Conductance Regulator

Stichwörter der Autor:innen

Cellular immune responseImmunologyInfectious diseaseInnate immunityMicrobiologyMouse models

Substanzen

Virulence FactorsBacterial ProteinsCystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, and.
  • Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Infectious Disease, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Division of Respiratory Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Department of Biomedical and Molecular Science, Queen's University, Kingston, Ontario, Canada.

Förderung

  • CIHR

Zitieren

APA

Qin, W., Brailsford, W., Cromer Berman, S., Thornton, C. S., DiGiandomenico, A., & Kubes, P. (2026). Targeting virulence factors Psl and PcrV restores host defense in bronchiectasis and cystic fibrosis models. Journal of Clinical Investigation, 136(22). https://doi.org/10.1172/jci205523

Vancouver

Qin W, Brailsford W, Cromer Berman S, Thornton CS, DiGiandomenico A, Kubes P. Targeting virulence factors Psl and PcrV restores host defense in bronchiectasis and cystic fibrosis models. Journal of Clinical Investigation. 2026;136(22). doi:10.1172/jci205523

BibTeX
@article{Qin2026,
  author = {Qin, Wanhai and Brailsford, Wayne and Cromer Berman, Stacey and Thornton, Christina S and DiGiandomenico, Antonio and Kubes, Paul},
  title = {Targeting virulence factors Psl and PcrV restores host defense in bronchiectasis and cystic fibrosis models},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {22},
  doi = {10.1172/jci205523}
}
Kostenlos starten →